Hematology Oncology Commercial Lead

The Oncology team is looking for a Commercial Director who will lead the commercial organization of Marketing and the customer-facing SME organization (HSP) for our growing Hematology Portfolio – Elrexfio and Besponsa. Elrexfio is expected to hit ~$100m in annual sales in 2025 and will be one of Pfizer Japan’s Top Priority Brands in OP26. Besponsa is indicated for Acute Lymphoblastic Leukemia (ALL) which is a cancer with a high unmet need. Besponsa is a smaller product of great reputational importance given the high unmet need it serves. Besponsa received approval for pediatric ALL in March 2024. This leadership role will be responsible for delivering ~$120m revenue target in 2026OP. The Director will manage an organization of ~15-17 people including ~6 Marketers and 1 HSP Customer Facing Team of 8-10, requiring seasoned leadership experience and people management skills. Specifically to lead customer facing team, the Director will set effective KPIs to assess HSP’s performance and guide the execution in the field.